Why Is ACADIA HEALTHCARE CO (ACHC) Stock Down Today?

Why ACHC stock is down today

ACHC stock is down 13.25% as of the latest trade at $28.36. The decline follows the release of the company's second-quarter 2026 earnings and guidance update. The stock opened with a 2.1% gap down and has since traded lower throughout the session, reaching a low of $28.13. The move reflects investor reaction to the company's financial disclosures and revised guidance.

What Happened

Acadia Healthcare Company, Inc. announced its second-quarter 2026 results and updated its full-year 2026 financial and cash flow guidance. The company filed an SEC 8-K on July 28, disclosing the results of operations and financial condition, along with a Regulation FD disclosure. A slide deck outlining the earnings call presentation was also published. The company reported adjusted earnings per share of $0.38 for the quarter, exceeding the $0.35 estimate. Revenue was reported at $865.839 million, surpassing the $844.232 million estimate. Despite these beats, the stock declined sharply after the report.

The company raised its full-year 2026 adjusted EPS guidance from $1.35 to $1.60 to $1.45 to $1.60, and raised its sales guidance from $3.370 billion to $3.450 billion to $3.400 billion to $3.450 billion. However, the market appears to have reacted negatively to the guidance, which some investors may have viewed as insufficiently aggressive given the company's broader performance.

What The Data Shows

The stock opened at $32.01 and has traded in a sharply declining pattern, reaching a low of $28.13. Volume has been light, with 0.2 million shares traded, which is 0.1 times the 3-month daily average. The stock is currently trading within its 52-week range of $11.43 to $35.83. Acadia Healthcare remains unprofitable, with a trailing twelve-month EPS of -12.24 and a net margin of -32.8%. The company has a market cap of $3.0 billion and a beta of 0.64.

What To Watch

The stock is currently trading below its 52-week low. Investors should monitor the company's ability to meet its updated guidance and the broader market's reaction to its performance.